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Shiga toxins (Stxs), which are proteins expressed by the enteric pathogens Shigella dysenteriae serotype 1 and
some serotypes of Escherichia coli, are potent protein synthesis inhibitors. Stx-producing organisms cause
bloody diarrhea with the potential to progress to acute renal failure and central nervous system complications.
Studies using animal models of these diseases have shown that Stxs are major virulence factors, and purified
toxins have been shown to be capable of killing many types of cells in vitro. We showed that Stx type 1 (Stx1)
rapidly induced apoptosis in undifferentiated, monocytic THP-1 cells through a mechanism involving the
endoplasmic reticulum (ER) stress response. Rapid apoptosis correlated with increased expression of C/EBP
homologous protein (CHOP), TRAIL, and DR5, while expression of the antiapoptotic factor Bcl-2 was down-
regulated. Stx1 treatment of differentiated, macrophage-like THP-1 cells was associated with cytokine produc-
tion and delayed apoptosis. The mechanisms contributing to cell maturation-dependent differences in re-
sponses to Stx1 are unknown. We show here that in macrophage-like cells, Stx1 activated the proximal ER
stress sensors RNA-dependent protein kinase-like ER kinase and inositol-requiring ER signal kinase 1 but
did not activate activating transcription factor 6. Proapoptotic signaling pathways mediated by CHOP and by
Bax and Bak were activated by Stx1. However, the toxin also activated prosurvival signaling through increased
expression, mitochondrial translocation, and alternative phosphorylation of Bcl-2.
Shiga toxins (Stxs), also called Shiga-like toxins or verotox-
ins, are potent protein synthesis inhibitors expressed by the
enteric pathogens Shigella dysenteriae (serotype 1) and Esche-
richia coli (select serotypes). Stxs act as virulence factors by
increasing the severity of bloody diarrhea and increasing the
likelihood of development of life-threatening postdiarrheal se-
quelae, such as acute renal failure (hemolytic-uremic syn-
drome) and central nervous system complications (40). S. dys-
enteriae serotype 1 expresses the prototypic Stx, while closely
related toxins expressed by E. coli can be classified into Stx type
1 (Stx1) and Stx2 (30). X-ray crystallographic analyses revealed
that all Stxs contain six protein subunits in an arrangement
described as an AB5 structure. Stx A-subunits possess N-gly-
cosidase activity that depurinates a specific unpaired adenine
residue from eukaryotic rRNA, leading to protein synthesis
inhibition in the intoxicated cell (11, 35). The pentameric B-
subunits are responsible for toxin binding to the cell surface
and interact with the neutral globo series glycolipid globo-
triaosylceramide (for a review, see reference 26). Toxin-mediated
receptor cross-linking through interaction with the pentameric
B-subunits is thought to trigger receptor-mediated endocyto-
sis. Once internalized, the toxins are sequentially delivered
from an early endosome to the trans-Golgi network, through
the Golgi apparatus, to the endoplasmic reticulum (ER), and
into the cytosol (for a review, see reference 34). The mecha-
nisms of toxin retrograde transport and retrotranslocation
across the ER membrane remain to be fully characterized.
Nevertheless, numerous reports indicate that the ER is the
ultimate cellular compartment for facilitated cytosolic delivery
of Stxs.
In addition to its role in cotranslational transport of nascent
polypeptides, the ER is the principal site for the correct folding
of proteins destined to enter the secretory pathway. A “protein
quality control” process which detects improperly folded pro-
teins and attempts to mediate correct folding has been char-
acterized. During the lifetime of a cell, the rates of protein
translocation into the ER lumen may vary. Cells may encoun-
ter conditions such as DNA damage, glucose deprivation, dis-
rupted calcium homeostasis, or hypoxia in which the capacity
of the ER to correctly fold proteins becomes saturated, a
condition referred to as ER stress (1, 10). Prolonged failure to
correctly fold and translocate proteins from the ER can lead to
induction of apoptosis (3, 32). Cells undergoing apoptosis dis-
play morphological changes such as cell membrane blebbing,
cell shrinkage, and nuclear fragmentation that produce apop-
totic bodies. ER stress-induced apoptosis is a critical factor in
the pathophysiology of a number of clinical conditions, includ-
ing Alzheimer’s disease, Creutzfeldt-Jakob disease, Hunting-
ton’s disease, cardiovascular dysfunction, and inflammatory
bowel disease (20, 21).
Stxs initiate apoptotic cell death in vitro via induction of
caspase-activated apoptotic signaling in many types of cells, in-
cluding human epithelial, endothelial, and myeloid cells (for a
review, see reference 4). Furthermore, renal epithelial cell apop-
tosis appears to be a characteristic of kidney damage in humans
with hemolytic-uremic syndrome (19). We have previously shown
that Stx1 induces apoptosis in the human myelogenous leukemia
cell line THP-1 in a cell maturation-dependent manner (14).
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Apoptosis is rapidly induced in undifferentiated, monocytic cells,
whereas in differentiated, macrophage-like cells there is slow on-
set of apoptosis preceded by a period of increased protein syn-
thesis and production of proinflammatory cytokines and chemo-
kines. Rapid Stx1-induced apoptosis in monocytic cells was
associated with activation of the ER stress response through the
sensors RNA-dependent protein kinase-like ER kinase (PERK),
inositol-requiring ER signal kinase 1 (IRE1), and activating
transcription factor 6 (ATF6). ER stress led to increased expres-
sion of the transcription factor C/EBP homologous protein
(CHOP), the apoptosis-inducing factor TRAIL, and the death
domain-containing receptor DR5, along with concomitant de-
creased expression of the prosurvival factor Bcl-2 (25). Some
members of the Bcl-2 family, including Bcl-2 and Bcl-xL, act as
antiapoptotic factors by inhibiting the mitochondrial uptake of
Ca2 and blocking the release of cytochrome c from mitochon-
drial stores into the cytoplasm and the subsequent formation of
the apoptosome. Other Bcl-2 proteins, such as Bax and Bak,
are involved in apoptosis induction (7, 16). The mechanism(s)
by which differentiation of THP-1 cells leads to transient in-
creases in protein synthesis and delayed apoptosis following
Stx treatment is unknown. We show here that, unlike treat-
ment of monocytic cells with purified Stx1, which triggers pri-
marily proapoptotic signaling cascades, treatment of macro-
phage-like THP-1 cells with purified Stx1 selectively activates
the ER stress sensors PERK and IRE1 to relay both pro-
apoptotic and prosurvival signals. The upregulated expression,
mitochondrial translocation, and differential phosphorylation
of the antiapoptotic factor Bcl-2 appear to be involved in the
capacity of macrophage-like cells to initially survive intoxica-
tion with Stx1.
MATERIALS AND METHODS
Materials. Antibodies directed against human phospho-PERK, phospho-
eukaryotic initiation factor 2 (phospho-eIF-2) (Ser51), IRE1, phospho-Bcl-2
(Ser70, Thr56), Bcl-2, Bcl-xL, Bax, Bak, BiP, and pan-actin were purchased from
Cell Signaling Technology, Beverly, MA. Rabbit polyclonal anti-phospho-IRE1
(Ser724) was purchased from Novus Biologicals, Inc., Littleton, CO. Anti-human
ATF6 antibody was obtained from IMGENEX, San Diego, CA. Total PERK and
CHOP (Gadd-153) antibodies were purchased from Santa Cruz Biotechnology
Inc., Santa Cruz, CA.
Cell culture. The human myelogenous leukemia cell line THP-1 (American
Type Culture Collection, Manassas, VA) was cultured in RPMI 1640 medium
(Gibco-BRL, Grand Island, NY) containing 10% fetal bovine serum (HyClone
Laboratories, Logan, UT), penicillin (100 U/ml), and streptomycin (100 g/ml)
at 37°C in 5% CO2 in a humidified incubator. Cells maintained under these
conditions were considered undifferentiated, monocytic cells. Monocytic cells
(1  106 cells/ml) were differentiated to the adherent macrophage-like state with
phorbol 12-myristate 13-acetate (PMA) (Sigma Chemical Co., St. Louis, MO) at
a concentration of 50 ng/ml for 48 h. Plastic-adherent cells were washed three
times with cold, sterile Dulbecco’s phosphate-buffered saline (Sigma Chemical
Co., St. Louis, MO) and then incubated with fresh medium lacking PMA but
containing 10% fetal bovine serum, penicillin (100 U/ml), and streptomycin (100
g/ml). The medium was changed every 24 h for the next 3 days. Experiments
were performed on the fourth day after PMA removal.
Stxs. Stx1 was expressed from E. coli DH5(pCKS112), a recombinant strain
harboring a plasmid containing the stx1 operon under the control of a thermoin-
ducible promoter (41). Cells were lysed, and periplasmic extracts were subjected
to sequential ion-exchange and chromatofocusing chromatography. The purity of
toxins was assessed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis
(SDS-PAGE) and Western blot analysis using anti-Stx1-specific antibodies. Prior
to use, Stx1 preparations were shown to contain 0.1 ng of endotoxin/ml by use
of the Limulus amoebocyte lysate assay (Associates of Cape Cod, East Falmouth,
MA). Purified Stx1A, a holotoxin with two point mutations (E167Q and
R170L) was a kind gift from Shinji Yamasaki, Osaka Prefecture University,
Osaka, Japan. The site-directed mutations were shown to reduce toxin N-glyco-
sidase activity by 5 logs (31). Purified pentameric Stx1 B-subunits were a kind gift
from Cheleste Thorpe, Tufts University School of Medicine, Boston, MA.
Total RNA extraction and semiquantitative RT-PCR. Undifferentiated and
differentiated THP-1 cells (5  106 cells/well) were not treated or treated for 0
to 24 h with Stx1, Stx1A (400 ng/ml), or thapsigargin (Tg) (10 M) in RPMI
1640 medium with 10% fetal bovine serum. Following treatment, total RNA was
isolated from cells using a phenol-free, filter-based RNA isolation system
(RNAqueous kit; Ambion, Austin, TX) according to the manufacturer’s instruc-
tions. Extracted total RNA was treated with RNase-free DNase at 37°C for 30
min to remove contaminating genomic DNA, and this was followed by heat
inactivation at 95°C for 20 min. The RNA concentration and purity were deter-
mined by spectrophotometry (Nanodrop Technologies Inc., LLC, Wilmington,
DE). Semiquantitative reverse transcription (RT)-PCR was performed using the
AccessQuick RT-PCR system (Promega, Madison, WI) according to the manu-
facturer’s protocol. The following target gene-specific PCR primers were used
for the reactions: for human Bax, forward primer 5-AAGCTGAGCGAGTGT
CTCAAGCGC-3 and reverse primer 5-TCCCGCCACAAAGATGGTCACG-
3; for human Bak, forward primer 5-TCCAGATGCCGGGAATGCACTGAC
G-3 and reverse primer 5-TGGTGGGAATGGGCTCTCACAAGG-3; for
human BiP, forward primer 5-TAGCGTATGGTGCTGCTGTC-3 and reverse
primer 5-TTTGTCAGGGGTCTTTCACC-3; and for human -actin, forward
primer 5-CTGTCTGGCGGCACCACCAT-3 and reverse primer 5-GCAAC
TAAGTCATAGTCCGC-3. CHOP and Bcl-2 primers were designed as previ-
ously reported (25). Amplification of the expected single PCR product was
confirmed using 1.5% agarose gels stained with ethidium bromide.
Detection of XBP-1 mRNA splicing. The method used for detection of un-
spliced and spliced X-box protein 1 (XBP-1) mRNA has been described previ-
ously (25). Briefly, RT-PCR products of XBP-1 mRNA were obtained from total
extracted RNA using forward primer 5-AAACAGAGTAGCAGCTCAGACT
GC-3 (sense) and reverse primer 5-ATCTCTAAGACTAGGGGCTTGGT-3
(antisense). Because a 26-bp fragment containing a PstI site is spliced upon
activation of XBP-1 mRNA, the RT-PCR products were digested with PstI
restriction enzyme to distinguish the active spliced form from the inactive un-
spliced form. Subsequent electrophoresis revealed that the inactive form is two
cleaved fragments and the active form is a noncleaved fragment.
Preparation of cellular lysates and Western blotting. Eighteen hours prior to
stimulation, differentiated THP-1 cells (5  106 cells/well) were serum starved in
RPMI 1640 medium containing 0.5% fetal bovine serum to reduce background
kinase signaling. Cells were stimulated with Stx1 (400 ng/ml), Stx1A (400 ng/ml),
Stx1 B-subunit (800 ng/ml), or Tg (10 m) for 0 to 24 h. Cells were harvested and
lysed with modified radioimmunoprecipitation assay buffer (1.0% Nonidet P-40,
1.0% sodium deoxycholate, 150 mM NaCl, 50 mM Tris-HCl [pH 7.5], 0.25 mM
sodium pyrophosphate, 2.0 mM sodium vanadate, 2.0 mM sodium fluoride, 10g/ml
aprotinin, 1.0 g/ml leupeptin, 1.0 g/ml pepstatin, 200 mM phenylmethylsulfonyl
fluoride) at 4°C. For detection of CHOP, cells were lysed with modified lysis buffer
(137 mM NaCl, 15 mM EGTA, 0.1 mM sodium orthovanadate, 15 mM MgCl2, 0.1%
Triton X-100, 25 mM MOPS [morpholinepropanesulfonic acid] [pH 7.2], 100 mM
phenylmethylsulfonyl fluoride, 20 M leupeptin). Extracts were collected and
cleared by centrifugation at 15,000  g for 10 min. Cell lysates from monocytic
THP-1 cells were prepared as previously described (25). The protein concentrations
of each extract were determined using a Micro BCA protein assay kit (Pierce,
Rockford, IL). Equal amounts of proteins (70 to 100 g/lane) were separated by 8%
or 12% Tris-glycine SDS-PAGE and transferred to nitrocellulose membranes. The
membranes were blocked with 5% nonfat milk prepared with 20 mM Tris (pH
7.6)-137 mM NaCl-0.1% Tween 20. The membranes were incubated with primary
antibodies at 4°C for 24 h. After washing, the membranes were incubated with
horseradish peroxidase-labeled secondary antibodies for 2 h at room temperature.
Bands were visualized using the Western Lightning chemiluminescence system
(NEN-Perkins Elmer, Boston, MA). The data shown below are data from at least
four independent experiments. Relative protein expression levels were measured
using the NIH Image J software.
Immunofluorescence confocal microscopy. Differentiated and undifferentiated
THP-1 cells were plated and cultured on eight-well LabTek chamber slides (Nalge
Nunc International, Rochester, NY) at a density of 5 104 cells/well. Cells grown on
chamber slides were treated with Stx1, Stx1A, or Stx1 B-subunits for 0 to 4 h. Cells
were stained with MitoTracker Red (300 nM; Invitrogen, Eugene, OR) and then
fixed with 4% paraformaldehyde for 15 min, permeabilized with 0.3% Triton X-100
for 4 min, and blocked with phosphate-buffered saline containing 1% bovine serum
albumin. After two washes with phosphate-buffered saline for 2 min, polyclonal
rabbit anti-human Bax-, Bak-, or Bcl-2-specific antibodies in blocking buffer were
added to the slides, and the cells were incubated in humidified 5% CO2 at 37°C for
2 h. After washing, fluorescein-conjugated goat anti-rabbit antibody (Vector Labo-
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ratories Inc., Burlingame, CA), and 4,6-diamidino-2-phenylindole (DAPI) (300
nM; Invitrogen) in blocking buffer were added together as a secondary antibody and
nuclear staining dye, respectively. After incubation for 1 h, slides were mounted on
Vectashield (Vector Laboratories Inc.), covered with glass coverslips, and examined
with a Stallion digital imaging station (Carl Zeiss Microscopy, Gottingen, Germany).
Quantification of Bax, Bak, and Bcl-2 mitochondrial translocation and nuclear frag-
mentation in confocal images was performed by counting at least 75 treated or
untreated cells per well from five independent experiments. Cells were scored pos-
itive for mitochondrial translocation if there was yellow or orange in merged images.
Fragmented nuclei were detected by punctate DAPI blue staining, and the results
were normalized using the total number of DAPI-stained cells.
Statistical analysis. The data are reported below as means 	 standard errors of
the mean (SEM) for at least four independent experiments. Statistical analyses of
data were performed with Excel (Microsoft, Redmond, WA). Student’s t test was
used to measure differences in samples. Depending on the assay, a P value of0.05,
0.005, or 0.001 was considered significant.
RESULTS
Stx1 induces ER stress in macrophage-like THP-1 cells
through activation of the sensor molecules PERK and IRE1.
We previously demonstrated that Stx1 induced ER stress in
monocytic THP-1 cells through the ER membrane-bound sen-
sors PERK, IRE1, and ATF6. Signaling through these mol-
ecules led to coordinate regulation of ER stress-associated
target proteins and rapid onset of apoptosis (25). To assess the
induction of ER stress in macrophage-like THP-1 cells, differ-
entiated cells were stimulated from 0 to 8 h with purified Stx1
or Stx1 mutant holotoxin Stx1A containing two point muta-
tions that dramatically reduce the enzymatic activity and the
ability to induce apoptosis. Tg, an irreversible inhibitor of the
sarcoplasmic ER Ca2 ATPase, was used as a positive control
for PERK activation. We observed persistent PERK activation
when cells were treated with Stx1; the activation peaked at a
4.1-fold increase (P  0.05) at 1 h and remained elevated (3.0-
fold increase; P  0.05) up to 8 h after treatment (Fig. 1A).
Both Stx1A and Tg mediated transient increases in PERK
phosphorylation that progressively decreased 6 to 8 h after
treatment. Consistent with these findings, we noted that treat-
ment of cells with Stx1 resulted in prolonged activation of the
FIG. 1. Stx1 induces ER stress through the sensors PERK and IRE1 in human macrophage-like THP-1 cells. Differentiated, macrophage-like
THP-1 cells (1.0  106 cells/ml) were stimulated with Stx1, the enzymatic mutant Stx1A (400 ng/ml), or Stx1 B-subunits (800 ng/ml). Tg (10 M)
was used as the positive control for activation of ER stress signaling. At the indicated times, cells were lysed, and the lysates were subjected to 8
to 12% SDS-PAGE followed by Western blotting (WB) using antibodies specific for the ER stress signaling molecules, including (A) PERK,
(B) IRE1, and (C) unprocessed 90-kDa ATF6. (Upper panels) Characteristic immunoblots; (lower panels) statistical analyses of densitometric
scans from at least four independent experiments. The data are expressed as mean 	 SEM increases in (A) phospho-PERK (P-PERK),
(B) phospho-IRE1 (p-IRE1) and total IRE1 (IRE1), and (C) total 90-kDa ATF6 levels compared to the levels in untreated control cells
(C) and were normalized using total PERK or actin levels. Asterisks indicate significant differences (P  0.05) compared to control cells.
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PERK substrate eIF-2 (http://medicine.tamhsc.edu/basic
-sciences/mmp/faculty/materials/tesh-bcl-2.html). At later time
points, PERK activation and eIF-2 activation were main-
tained up to 16 h after Stx1 treatment (2.8-fold increase; P 
0.05) and returned to basal levels at 24 h. Stx1A did not
induce PERK or eIF-2 activation at later time points (data
not shown). As was the case for monocytic THP-1 cells, Stx1
increased IRE1 release in soluble fractions of macrophage-
like cells, which peaked at a 2.1-fold increase 16 h after toxin
treatment (Fig. 1B). We also observed a transient increase in
IRE1 phosphorylation at Ser724, a well-described character-
istic of the ER stress response. IRE1 phosphorylation re-
mained at basal levels following Stx1A and Stx1 B-subunit
treatment (Fig. 1B, lower panel). Activation of the IRE1
endonuclease function by Stx1 treatment was shown by splicing
of the XBP-1 transcript (http://medicine.tamhsc.edu/basic
-sciences/mmp/faculty/materials/tesh-bcl-2.html). Interestingly, the
total levels of XBP-1 transcripts were also increased 6 h after
Stx1 treatment. In contrast to the findings for monocytic
THP-1 cells, in which Stx1 treatment rapidly triggered ATF6
processing (25), we did not detect ATF6 proteolysis (loss of the
90-kDa unprocessed protein) after treatment of macrophage-
like THP-1 cells with Stx1 (Fig. 1C). Slightly elevated levels of
unprocessed ATF6 were detected by immunoblotting after
toxin treatment. Collectively, these data suggest that, unlike for
monocytic THP-1 cells, where Stx1 signals through all ER
stress sensors, the toxin selectively activates the sensor mole-
cules PERK and IRE1, but not ATF6, in macrophage-like
cells. Furthermore, toxin enzymatic activity appears to be nec-
essary for prolonged sensor activation.
Stx1 intoxication of THP-1 cells leads to increased expres-
sion of the ER stress target molecules CHOP and BiP. The
transcription factor CHOP and the ER resident chaperone BiP
are regulated by ER stress signal transducers responding to
unfolded proteins within the ER lumen (15, 22). We previously
showed that CHOP mRNA expression and CHOP protein
expression were upregulated in undifferentiated THP-1 cells
following treatment with Stx1 over a 12-h period (25). Based
on these previous data and our demonstration of PERK and
IRE1 activation, we hypothesized that Stx1 activates CHOP
expression in macrophage-like THP-1 cells. Cells were stimu-
lated with Stx1 for 0 to 24 h, and CHOP transcript and protein
levels were measured by RT-PCR and immunoblotting, re-
spectively. Treatment of differentiated THP-1 cells with Stx1
induced CHOP transcript expression (Fig. 2A) and protein
expression (Fig. 2B) that were elevated 2 to 4 h after treatment
but decreased at later time points. Although capable of tran-
sient PERK activation, Stx1A did not elicit CHOP mRNA or
protein expression 4 h after treatment. At later time points, the
Stx1A holotoxin and Stx1 B-subunits caused increases in
CHOP protein levels only at single time points (6 and 12 h,
respectively); however, Stx1A and Stx1 B-subunits did not
trigger apoptosis (14). The sarcoplasmic ER Ca2 ATPase
inhibitor Tg was a potent inducer of CHOP protein expression
(data not shown).
Under normal homeostatic conditions, proximal sensors of
unfolded proteins remain associated with chaperone proteins,
such as BiP, at the ER membrane (2). In the presence of
elevated levels of improperly folded proteins, chaperones dis-
sociate from ER stress sensors and bind unfolded proteins. BiP
dissociation from the sensors is thought to be crucial for sensor
dimerization and activation. Given the evidence that Stxs bind
to chaperones (12, 43) and activate the ER stress response, we
reasoned that chaperone protein expression may be altered by
Stx1 treatment. We treated monocytic and macrophage-like
THP-1 cells with Stx1 or Tg for 0 to 120 min and then isolated
FIG. 2. Stx1 induces CHOP expression in THP-1 cells. (A) Macrophage-like THP-1 cells were treated with Stx1 for 0 to 24 h or with Stx1 or
Stx1A for 0 to 4 h. To measure changes in CHOP transcript levels, RT-PCR was performed as described in Materials and Methods. Resultant
cDNAs were resolved on 1.5% agarose gels and visualized using ethidium bromide. (B) Macrophage-like THP-1 cells were treated with Stx1 for
0 to 24 h or with Stx1 or Stx1A for 0 to 2 h. CHOP expression and -actin protein expression following Stx1 treatment for the indicated times
were determined by Western blotting (WB). The bar graphs show the results of statistical analyses of data from densitometric scans from four
independent experiments, and the data are expressed as mean and SEM increases in CHOP mRNA or protein levels compared to the levels in
untreated control cells (C) and were normalized using -actin levels. Asterisks indicate significant differences (P 0.05) compared to control cells.
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total RNA for RT-PCR quantitation of BiP mRNA expression
or prepared cell lysates for immunoblotting. Stx1-induced ER
stress led to rapid (within 15 min) increases in BiP mRNA
levels, which declined at 120 min after toxin treatment in both
monocytic and macrophage-like THP-1 cells (Fig. 3A). BiP
protein levels in Stx1-treated cells were correlated with mRNA
results, showing that there was increased BiP expression within
15 min after toxin treatment (Fig. 3B). To examine the roles of
toxin enzymatic activity and B-subunit retrograde transport in
increased BiP expression, we treated monocytic and macro-
phage-like THP-1 cells with Stx1, Stx1A, or purified Stx1
B-subunits for 30 min. Cell lysates were prepared, and equal
concentrations of proteins were transferred to membranes for
probing with anti-BiP antibodies. All of the Stx1 treatments
induced higher levels of BiP expression compared to the re-
sults for untreated control cells (Fig. 3B, lower panels). These
data suggest that following retrograde transport to the ER,
individual toxin subunits may be “sensed” as misfolded pro-
teins, leading to increased expression or stabilization of the
chaperone BiP. In contrast, activation of the transcription fac-
tor CHOP appears to require enzymatic activity.
Stx1 transiently increases Bax and Bak expression and in-
duces translocation of these molecules to mitochondria in
THP-1 cells. Stx1 induces the release of Ca2 from ER stores
in THP-1 cells (6, 25). In response to elevated levels of mis-
folded proteins in the ER, the BH1-3-containing proapoptotic
proteins Bax and Bak associate with the ER membrane to
create Ca2-specific pores. The efflux of Ca2 from ER stores
contributes to activation of the intrinsic apoptotic pathway.
Thus, maintenance of Ca2 homeostasis is a control factor in
apoptosis (36). ER stress-activated release of Ca2 from ER
stores may induce apoptosis in part through transcriptional
and translational activation of Bax and Bak expression. There-
fore, we determined whether Stx1 induced the expression of
Bax and Bak mRNA and proteins in monocytic and macro-
phage-like THP-1 cells. Characteristic immunoblots are shown
in Fig. 4A, while the results of statistical analyses of data
derived from four independent experiments are shown in the
bar graphs. Increased expression of the Bax and Bak proteins
was detected 15 min after Stx1 treatment of monocytic cells,
and the expression of these proteins peaked at 15 min (3.3-
fold; P  0.005) and 30 min (2.3-fold; P  0.05), respectively.
FIG. 3. Stx1 induces BiP expression in THP-1 cells. (A) Following treatment with Stx1 or Tg for the indicated times, total RNA was extracted
from monocytic or macrophage-like THP-1 cells. RT-PCR using primers specific for BiP were used to assess BiP mRNA induction. (B) Following
treatment with Stx1 or Tg for 0 to 2 h (upper panels) or treatment with Stx1, Stx1A, or purified Stx1 B-subunits (Stx1B) for 30 min (lower panels),
cell lysates were prepared from monocytic or macrophage-like THP-1 cells. Equal amounts of proteins were subjected to Western blot (WB)
analysis using antibodies specific for BiP or -actin. The bar graphs show the results of statistical analyses of data derived from four independent
experiments. The data are expressed as mean and SEM increases in BiP mRNA or protein levels compared to the levels in untreated control cells
(C) and were normalized using -actin levels. Asterisks indicate significant differences (P  0.05) compared to control cells.
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Stx1 also increased Bax and Bak expression in macrophage-like
cells, although the induction kinetics were delayed compared
to those in monocytic cells. Elevated levels of Bax and Bak
protein expression were observed with Stx1, Stx1A, or Stx1
B-subunit treatment after 30 min (Fig. 4B), suggesting that
toxin enzymatic activity is not required for increased expres-
sion. Stx1 treatment was associated with rapid induction of bax
transcripts in the monocytic THP-1 cells (4.4-fold increase,
peaking at 15 min; P  0.001), while increases in bax mRNA
levels in macrophage-like cells were slightly delayed (2-fold
increase, peaking at 30 min; P  0.05) (http://medicine.tamhsc
.edu/basic-sciences/mmp/faculty/materials/tesh-bcl-2.html).
Bax and Bak translocation and association with the mito-
chondrial membrane trigger the intrinsic pathway of apoptosis
(28, 33). To study the involvement of Stx1 in triggering
mitochondrial translocation of Bax, we performed confocal
fluorescence microscopy with Stx1-treated monocytic and mac-
rophage-like THP-1 cells using fluorescein isothiocyanate-con-
jugated anti-Bax antibody and MitoTracker Red (Fig. 5A). Bax
rapidly translocated to mitochondria of monocytic cells, and
33% of the cells (P  0.001) showed punctuate yellow fluores-
cence in merged images 15 min after toxin treatment. There
was extensive nuclear fragmentation in Stx1-treated monocytic
cells at 4 h, suggesting that there was rapid apoptosis following
intoxication. Bax translocation was delayed in macrophage-like
cells, and 22% of the total cells (P  0.01) showed evidence of
Bax association with mitochondria 60 min after intoxication.
Nuclear fragmentation was not observed following short-term
treatment of macrophage-like cells with Stx1. In contrast to the
results for Stx1 treatment, Bax mitochondrial translocation and
nuclear fragmentation were not observed after Stx1A holo-
toxin or Stx1 B-subunit treatment for 4 h, suggesting that Stx1
enzymatic activity is required to relay signals to induce apop-
tosis (Fig. 5A). We observed mitochondrial translocation of
Bak in macrophage-like cells treated with Stx1 for 1 h (Fig.
5B). Quantitative analysis showed that the number of cells with
translocated Bak was significantly greater for Stx1-treated cells
(34.3% of total cells; P  0.001) than for control cells. Stx1A
and Stx1 B-subunits did not induce Bak mitochondrial trans-
location (data not shown). Tg was used as a positive control for
confocal imaging of Bax and Bak translocation (data not
shown).
Stx1 induces expression of the antiapoptotic factor Bcl-2,
which associates with mitochondria in macrophage-like cells.
Our observation that the onset of apoptosis mediated by Stx1
in macrophages is delayed compared to that in monocytic cells
suggested that Stx1 triggers alternative signaling pathways in
differentiated cells responsible for the transient survival phe-
notype. One possible explanation for the longer life span of
macrophage-like THP-1 cells following intoxication may be
expression of antiapoptotic members of the Bcl-2 family of
apoptosis regulators. We previously observed decreased levels
of Bcl-2 transcripts beginning 2 h after toxin treatment of
monocytic THP-1 cells (25). To address whether changes in
Bcl-2 expression are correlated with cell survival following
toxin challenge, Bcl-2 and Bcl-xL mRNA and protein levels
FIG. 4. Stx1 induces transient expression of the proapoptotic factors Bax and Bak in THP-1 cells. (A) Monocytic and macrophage-like THP-1
cells were treated with Stx1 or the ER stress inducer Tg for the indicated times. Cell lysates were prepared, and equal amounts of protein were
subjected to Western blot (WB) analysis for Bax, Bak, and actin expression. Characteristic immunoblots are shown in the upper panels.
(B) Monocytic and macrophage-like THP-1 cells were treated with Stx1, Stx1A, or Stx1 B-subunits for 30 min, and Bax, Bak, and actin expression
was determined by Western blotting (WB). The bar graphs show the results of statistical analyses of data derived from five independent
experiments. The data are expressed as mean 	 SEM increases in Bax or Bak expression compared to the expression in untreated control cells
(C) and were normalized using actin expression. Asterisks indicate significant differences (*, P  0.05; **, P  0.005) compared to control cells.
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were analyzed at various times after treatment of macrophage-
like cells with Stx1. Stx1 treatment increased Bcl-2 mRNA
expression, which peaked at 2 to 4 h after toxin exposure and
declined to levels near control levels in 24 h (Fig. 6A), and it
also increased Bcl-2 protein expression, which remained ele-
vated for 12 h after toxin treatment (Fig. 6B). To examine
whether enzymatic activity or purified B-subunits affect anti-
apoptotic signaling, macrophage-like cells were exposed to
Stx1, Stx1A holotoxin, or Stx1 B-subunits for 6 or 12 h, which
was followed by Western blotting to measure Bcl-2 expression
(Fig. 6C). Bcl-2 induction was observed with all treatments,
suggesting that enzymatic activity is not required and B-subunit
retrograde transport is sufficient for Bcl-2 induction. Stx1 did
not appear to alter expression of the Bcl-xL protein in either
monocytic or macrophage-like THP-1 cells (Fig. 6D). Thus, in
contrast to monocytic THP-1 cells, which downregulate expres-
sion of the antiapoptotic factor Bcl-2 and undergo rapid cell
death, macrophage-like cells persistently express Bcl-2, which
may initially counterbalance apoptotic signaling triggered by
Stx1.
The prosurvival functions of Bcl-2 remain to be fully char-
acterized, but they may involve association of Bcl-2 with pro-
apoptotic members of the Bcl-2 family of proteins, such as Bax
and Bak, at the mitochondrial membrane, which blocks cyto-
chrome c release and subsequent formation of the apoptosome
(7, 16). Confocal microscopy with fluorescein isothiocyanate-
labeled (green) anti-Bcl-2 antibodies and MitoTracker Red
was employed to examine the subcellular localization of Bcl-2
following treatment of monocytic and macrophage-like THP-1
cells with Stx1 for 4 h and 12 h (Fig. 7A). In monocytic cells,
the overall Bcl-2-associated fluorescence was reduced by toxin
treatment compared to that in control cells, and significantly
reduced numbers of cells showed Bcl-2 colocalization with
mitochondria (Fig. 7B). In macrophage-like cells, the Bcl-2
signal did not diminish over time, and colocalization of Bcl-2
with mitochondria was evident in merged images. Again, we
noted extensive nuclear fragmentation and cell shrinkage in
monocytic cells, while nuclei of macrophage-like THP-1 cells
were not as severely damaged (Fig. 7C).
Stx 1 induces differential phosphorylation of Bcl-2 in mono-
cytic and macrophage-like THP-1 cells. Stx1 has been shown to
trigger the stress-activated JNK and p38 mitogen-activated
protein kinase (MAPK) cascades in many types of cells (5, 17,
37), and the activation of apoptotic and survival signaling by
Stx1 in macrophage-like THP-1 cells is associated with pro-
longed activation of JNK and p38 MAPKs (24). Ito et al. (18)
noted that phosphorylation of Bcl-2 at Ser70 may be required
for full and potent antiapoptotic activity. However, alternative
phosphorylation of Bcl-2 by p38 MAPK, particularly at Thr56,
was reported to inhibit antiapoptotic activity (8). We therefore
examined the phosphorylation status of Bcl-2 in monocytic and
macrophage-like THP-1 cells treated with Stx1 (Fig. 8). Stx1
treatment of monocytic cells was associated with the loss of
Ser70-phospho-Bcl-2 and Thr56-phospho-Bcl-2 6 h after toxin
exposure, a time at which a significant fraction of monocytic
cells were apoptotic. In macrophage-like cells, the levels of
FIG. 5. Mitochondrial translocation of Bax and Bak in Stx1-treated THP-1 cells. (A) Monocytic (upper panels) and macrophage-like (lower
panels) THP-1 cells were treated or not treated with Stx1 (400 ng/ml), Stx1A (400 ng/ml), or Stx1 B-subunits (800 ng/ml) for the indicated times.
Cells were treated with 300 nM Mitotracker Red for detection of mitochondria, fixed, permeabilized, and stained with anti-Bax primary antibodies
for 2 h at 37°C. After washing, cells were stained with secondary fluorescein-conjugated antibody for Bax detection (green) and DAPI (blue) for
nuclear staining. After mounting, cells were visualized by confocal laser microscopy. Note the colocalization of Bax with mitochondria in merged
images. Increased resolution of merged images is shown in the insets. Scale bars 
 10 m; original magnification, 63. (B) Differentiated THP-1
cells (5  105 cells/ml) were plated on eight-well chamber slides and stimulated with Stx1 (400 ng/ml) for 1 h. The method described above was
used for confocal microscopy, except that anti-Bak as used as the primary antibody. For quantitative analyses of confocal images, cells with
evidence of Bax or Bak mitochondrial translocation (orange or yellow in merged images) were counted for each treatment and scored for four
independent experiments. The bar graphs show the percentages (means 	 SEM) of cells with Bax or Bak translocation normalized to the total
cell number. Statistical significance (#, P  0.01; *, P  0.001) was assessed by comparing control (C) and Stx1 treatments.
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Ser70-phospho-Bcl-2 and Thr56-phospho-Bcl-2 in untreated
(control) cells were dramatically reduced compared to the
levels in control monocytic cells. However, the phosphoryla-
tion of Bcl-2 at Ser70 was significantly increased compared with
that in control cells after treatment with Stx1 for 1 and 2 h
(2.8-fold increase [P  0.05] and 4-fold increase [P  0.05],
respectively). Thr56-phospho-Bcl-2 was not detectable throughout
the time course of the experiment. Thus, Stx1 differentially
regulates Bcl-2 phosphorylation events in THP-1 cells in a cell
maturation-dependent manner. Monocytic cells maintain ex-
pression of the attenuated form of Bcl-2. Differentiated cells
dramatically upregulate phosphorylation of the antiapoptotic
form of the molecule, while the inactive form of Bcl-2 is un-
detectable.
DISCUSSION
We have shown that Stx1, a bacterial toxin routed to the ER,
induces apoptosis in the human myeloid cell line THP-1 in a
cell maturation-dependent manner. Monocytic cells were rap-
idly killed by this toxin through mechanisms involving (i) the
activation of ER stress sensors; (ii) the release of Ca2 from
ER stores, leading to calpain activation and proteolysis of
procaspase-8; and (iii) the production of TRAIL and DR5,
leading to caspase-8 activation. In contrast, macrophage-like
THP-1 cells displayed delayed apoptosis when they were
treated with Stx1, which was accompanied by transient in-
creases in total protein synthesis and cytokine and chemokine
production (14, 23). We show here that cell maturation is
associated with changes in the ER stress response, leading to
activation of proapoptotic and counterbalancing prosurvival
signals. A comparison of the signaling pathways activated by
Stx1 in monocytic and macrophage-like THP-1 cells is shown in
Table 1. While all three proximal ER stress sensors were ac-
tivated in monocytic cells, Stx1 activated PERK and IRE1, as
well as their downstream substrates eIF-2 and XBP-1, in
macrophage-like cells. Thus, differentiation appeared to be
associated with the loss of proteolysis and signaling through
the bZIP transcription factor ATF6. In response to ER stress,
membrane-bound ATF6 is cleaved by site 1 and site 2 pro-
teases that separate the active transcription factor from the
transmembrane domain. Activated ATF6 binds to promoters
FIG. 6. Induction of antiapoptotic factors Bcl-2 and Bcl-xL in Stx1-treated macrophage-like THP-1 cells. (A) THP-1 cells were not treated or
treated with Stx1 (400 ng/ml), and at the indicated time points total RNA was isolated to perform RT-PCR using a specific primer set for bcl-2
transcript analysis. -Actin mRNA expression was measured as an internal control under the same conditions that were used for bcl-2 mRNA
induction. (B) THP-1 cells were treated with Stx1 for the indicated times. Cell lysates were prepared, and equal amounts of protein were subjected
to Western blot (WB) analysis for Bcl-2 and actin expression. (C) THP-1 cells were not treated or treated with Stx1, Stx1 A, or Stx1 B-subunits,
and at the indicated times cell lysates were prepared. Equal amounts of protein were subjected to Western blot (WB) analysis for Bcl-2 expression.
The bar graphs in panels A to C show the results of statistical analyses of data derived from four independent experiments. The data are expressed
as mean and SEM increases in Bcl-2 expression compared to the expression in untreated control cells (C) and were normalized using actin
expression. Asterisks indicate significant differences (*, P  0.05; **, P  0.001) compared to control cells. (D) Bcl-xL protein expression levels
were determined by Western blot analysis using anti-human Bcl-xL monoclonal antibodies. Band intensities were measured by densitometry, and
changes are indicated below the lanes. Actin protein levels were used as equal protein loading controls. The results shown are representative of
the results of four independent experiments.
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containing ER stress elements (ERSE), which are complex
cis-active promoter elements that also contain binding sites for
CBF/NF-Y and TATA-binding protein (27, 42). Many ER
stress-regulated genes, including those encoding BiP and
CHOP, contain ERSE, and we have shown that both BiP
expression and CHOP expression are increased by Stx1 treat-
ment of monocytic and macrophage-like THP-1 cells. How
does Stx1 induce the increased expression of BiP and CHOP in
macrophage-like cells in the absence of ATF6 activation? Pre-
vious studies have shown that the endonuclease function of
IRE1 splices the XBP-1 transcript to form the active tran-
scription factor, and activated XBP-1 may also bind to ERSE
in a CBF/NF-Y-dependent manner. Thus, redundant signaling
functions of IRE1 appear to be capable of compensating for
the loss of ATF6 activation.
In a previous study using monocytic THP-1 cells, we noted
that the Stx1A holotoxin failed to activate PERK and ATF6
in monocytic cells (25). In the present study, we showed that
Stx1A transiently activates PERK and does not activate
IRE1 in macrophage-like cells. Stx1A and purified Stx1
B-subunits were capable of signaling increased BiP expression,
but the enzymatic mutant did not elicit persistent increases in
CHOP expression in monocytic (25) or macrophage-like
THP-1 cells. Since the E167Q R170L double mutation in
Stx1A holotoxin conferred a 5-log reduction in Vero cell
toxicity (31), it is unlikely that the transient PERK activation
and increased BiP expression were due to residual enzymatic
activity. These data suggest that the introduction of Stx1,
Stx1A holotoxin, or Stx1 B-subunits into the ER lumen per se
may be sufficient to trigger ER stress leading to association of
chaperone proteins with the toxins and ER stress sensor acti-
vation for increased BiP expression. However, Stx1A holo-
toxin and Stx1 B-subunits do not trigger programmed cell
death. Prolonged CHOP expression, which has been associated
with induction of apoptosis in vitro and in vivo (13, 38), may
require toxin enzymatic activity. Thus, ongoing generation of
truncated and/or misfolded host proteins may be necessary for
signaling leading to apoptosis. These studies focused on the
FIG. 7. Mitochondrial translocation of Bcl-2 in Stx1-treated THP-1 cells. (A) Monocytic and macrophage-like THP-1 cells were treated with
or without Stx1 for 4 h or 12 h. Cells were treated with 300 nM Mitotracker Red for detection of mitochondria, fixed, permeabilized, and stained
with anti-Bcl-2 primary antibodies. After washing, cells were stained with secondary fluorescein-conjugated antibody for Bcl-2 detection (green)
and with DAPI (blue) for nuclear staining. After mounting, cells were visualized by confocal laser microscopy. Note the extensive nuclear
fragmentation and lack of Bcl-2 colocalization with mitochondria in Stx1-treated monocytic cells. In toxin-treated macrophage-like cells, note the
colocalization of Bcl-2 with the nucleus and mitochondria in the merged image. For quantitative analyses of confocal images, cells with evidence
of Bcl-2 mitochondrial translocation (orange or yellow in merged images) or nuclear fragmentation were counted for each treatment and scored
for four independent experiments. The bar graphs show the mean 	 SEM percentages of cells with (B) Bcl-2 translocation or (C) nuclear
fragmentation normalized using the total cell number. The statistical significance of Bcl-2 translocation was assessed by comparing control and Stx1
treatments (*, P  0.05; **, P  0.001). Scale bar 
 10 m; original magnification, 63.
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response of human macrophage-like cells to Stx1. However,
epidemiological studies have indicated that infection with Stx2-
producing E. coli is more likely to progress to life-threatening
extraintestinal complications such as hemolytic-uremic syn-
drome (for a review, see reference 40), and use of purified
toxins in animal models revealed that Stx2 is more toxic (41).
Therefore, comparative studies of ER stress and induction of
apoptosis by Stx1 and Stx2 are in progress.
Members of the Bcl-2 family regulate the release of cyto-
chrome c from mitochondria. The proapoptotic Bcl-2 proteins
Bax and Bak form channels within the mitochondrial outer
membrane that disrupt the membrane potential, resulting in
cytochrome c release. Stx1 triggered a rapid, transient increase
in the level of bax and bak mRNA, which peaked at 30 min
after treatment of monocytic and macrophage-like THP-1
cells. The Bax and Bak protein levels also increased in both
types of cells. Confocal microscopy studies showed that Bax
rapidly translocated to the mitochondria following toxin treat-
ment of the cells. Bcl-2 and Bcl-xL possess antiapoptotic func-
tions that may act by blocking the mitochondrial outer mem-
brane permeabilization caused by the proapoptotic Bcl-2
family members Bax and Bak (7). Stx1A holotoxin and Stx1
FIG. 8. Effect of Stx 1 on site-specific Bcl-2 phosphorylation in THP-1 cells. Monocytic and macrophage-like THP-1 cells were stimulated with
Stx1 for the indicated time periods. Cell extracts containing 100 g of protein were subjected to Western blot (WB) analysis to measure levels of
expression of Bcl-2 phosphorylated at Ser70 or Thr56. Detection of actin levels served as a loading control. Mean 	 SEM changes in Ser70-
phospho-Bcl-2 levels compared to the levels in untreated control cells from at least four independent experiments are shown in the lower panel.
Asterisks indicate significant differences (*, P  0.05; **, P  0.01) compared to control cells (C).
TABLE 1. Signaling pathways activated by Stx1 in monocytic and macrophage-like THP-1 cells
Cells
Estimated time
to reach 50%
apoptosis with
Stx1 (h)a
Activation of ER stress
sensors
Expression
of ER stress
effectors
Expression of
proapoptotic
factors Bax and
Bak
Bax and Bak
mitochondrial
translocation
Expression of
prosurvival
factors
Bcl-2
phosphorylation
PERK Ire1 ATF6 CHOP BiP Bcl-2 Bcl-xL
Ser70-
phospho-
Bcl-2
Thr56-
phospho-
Bcl-2
Monocytic THP-1 5 b b b b  1 (transient)  2b c 2 c
Macrophage-like THP-1 24      1 (transient)  1 c 1 NDd
a Data from reference 14.
b Data from reference 25.
c No change detected.
d ND, not detected.
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B-subunit signals increased Bax and Bak expression and trig-
gered release of Ca2 from ER stores in monocytic and mac-
rophage-like THP-1 cells (6, 25). Increased Bax and Bak ex-
pression potentiates Ca2 release from ER stores (39).
However, treatment with the enzymatically deficient Stx1A
holotoxin and Stx1 B-subunits was not sufficient to cause mi-
tochondrial translocation of proapoptotic factors, despite ele-
vation of Bax and Bak expression. Thus, Ca2 release triggered
by Stx1 A or Stx1 B-subunits may not contribute to apoptosis
and not activate the mitochondrial or intrinsic pathway.
The major difference that we have observed between the
Stx1-induced ER stress response in monocytic cells and the
Stx1-induced ER stress response in macrophage-like cells in-
volves the antiapoptotic protein Bcl-2. Bcl-2 transcript expres-
sion was downregulated within 4 h of Stx1 treatment of mono-
cytic cells (25), while the Bcl-2 transcript levels increased and
peaked 4 h after toxin treatment in macrophage-like cells.
Increases in transcript levels correlated with increased Bcl-2
protein levels that were maintained for up to 12 h after toxin
treatment. This differential response was specific to Bcl-2 as
the levels of Bcl-xL, another antiapoptotic member of the Bcl-2
family, were not altered by Stx treatment in monocytic and
macrophage-like cells. In addition to quantitative changes in
Bcl-2 protein levels, we observed differences in Bcl-2 protein
translocation in the two differentiation states. In monocytic
cells, Bcl-2 proteins remained in a punctate pattern and did not
colocalize with mitochondria following toxin treatment. We
also observed significant nuclear fragmentation in monocytic
cells 4 h after toxin treatment. In contrast, Bcl-2 rapidly colo-
calized with mitochondria and nuclei following intoxication of
macrophage-like cells, and we did not detect extensive changes
in nuclear morphology after toxin exposure. Signaling through
the MAPK ERK1/2 or JNK, resulting in phosphorylation of
Bcl-2 at Ser70 and other serine and threonine residues, appears
to be necessary for the antiapoptotic function (9, 18). Specif-
ically, phosphorylation of Bcl-2 at Ser70 appears to facilitate
Bcl-2 dimerization or Bcl-2–Bcl-xL heterodimerization (29).
Recently, evidence was presented that p38 MAPK-dependent
phosphorylation of Bcl-2 at Thr56 and Ser87 induced confor-
mational changes that reduced the antiapoptotic potential (8).
Thus, alternative phosphorylation states appear to be critical in
posttranslational regulation of Bcl-2 function. We observed
differential Bcl-2 phosphorylation patterns in Stx1-treated
THP-1 cells. Control monocytic cells expressed Bcl-2 proteins
phosphorylated at Ser70 and Thr56. The Ser70- and Thr56-phos-
pho-Bcl-2 levels decreased rapidly in Stx1-treated monocytic
cells. In contrast, Ser70-phospho-Bcl-2 levels were upregulated
in Stx1-treated macrophage-like cells, and expression was
maintained for up to 16 h. Thr56-phospho-Bcl-2 was undetect-
able in control macrophage-like cells, and its expression was
not induced by Stx1. Collectively, the data suggest that the
delayed apoptosis phenotype in Stx1-treated macrophage-like
cells was associated with activation of prosurvival signaling,
increased expression of Bcl-2, translocation of the protein to
the mitochondria, and changes in Bcl-2 phosphorylation status
such that Bcl-2 phosphorylation at position 70 is increased and
prolonged.
In summary, we have shown that myeloid cells respond to
Stx1 in vitro in a cell maturation-dependent manner. Mono-
cytic THP-1 cells undergo rapid apoptosis without the produc-
tion of soluble cytokines. Toxin treatment of differentiated
cells is associated with cytokine production and delayed onset
of apoptosis. Rapid apoptosis in monocytic cells is associated
with robust activation of all ER stress sensors, leading to in-
creased expression of CHOP, TRAIL, and DR5, decreased
expression of the Bcl-2 protein, and loss of Ser70-phospho-
Bcl-2. Delayed onset of cell death in macrophage-like cells was
associated with loss of signaling through ATF6, increased ex-
pression of CHOP and Bcl-2, and increased expression of
Ser70-phospho-Bcl-2 with a concomitant loss of Thr56-phos-
pho-Bcl-2. Collectively, these data suggest that Bcl-2 protects
macrophage-like cells from rapid apoptosis induced by Stxs.
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